Omers

OMERS, a Canadian public pension fund, manages C$124 billion in assets for over half a million members across Ontario. The fund invests globally in a diverse portfolio of high-quality assets to fulfill its pension promise. OMERS focuses on sustainability and long-term value creation, balancing current needs with future obligations.

Notable investments include BioCryst Pharmaceuticals and Northvolt. OMERS' world-class team employs a purposeful investment strategy, emphasizing the best interests of plan members and sponsors. The fund's approach combines financial performance with responsible investing practices, aiming to deliver sustainable returns for its beneficiaries.